TB diagnostics and laboratory strengthening
The landscape of TB diagnostics continues to evolve, with new technologies at various stages in the product development pipeline. WHO follows a systematic process for development of policy recommendations, involving synthesis of the available data through systematic reviews, assessment of the evidence by a Guideline Development Group using the GRADE approach, and development of policy guidance for dissemination to Member States and other stake holders.
Guideline Development Group Meeting
WHO convened a Guideline Development Group (GDG) WebEx meeting in Geneva, Switzerland on 23 August 2016 to review evidence on the use of Xpert MTB/RIF for potential update of WHO policy. More details regarding the meeting, the list of participants and their bio-data are available here: